|
Volumn 47, Issue 4, 1998, Pages 148-151
|
Methotrexate hepatotoxicity: What is the evidence?
a a a |
Author keywords
Cirrhosis; Fibrosis; Liver function; Methotrexate
|
Indexed keywords
METHOTREXATE;
ARTHROPATHY;
CLINICAL TRIAL;
FATTY LIVER;
HUMAN;
LIVER BIOPSY;
LIVER CIRRHOSIS;
LIVER FIBROSIS;
LIVER FUNCTION TEST;
LIVER TOXICITY;
POLYMYOSITIS;
PRACTICE GUIDELINE;
PSORIASIS;
REITER SYNDROME;
RHEUMATOID ARTHRITIS;
RISK FACTOR;
SHORT SURVEY;
SYSTEMIC LUPUS ERYTHEMATOSUS;
UVEITIS;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
DERMATOLOGIC AGENTS;
HUMANS;
LIVER;
LIVER CIRRHOSIS;
LIVER FUNCTION TESTS;
METHOTREXATE;
PSORIASIS;
RISK ASSESSMENT;
|
EID: 0031944935
PISSN: 10233830
EISSN: None
Source Type: Journal
DOI: 10.1007/s000110050307 Document Type: Short Survey |
Times cited : (17)
|
References (32)
|